Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06087263 |
|---|---|
| Brief Title: | Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting. |
| First Submitted : | October 12, 2023 |
| First Submitted that Met QC Criteria : | October 12, 2023 |
| First Posted : | October 17, 2023 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 23, 2024 |